Showing 2,021 - 2,040 results of 17,084 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((teer decrease) OR (mean decrease)) ))', query time: 1.12s Refine Results
  1. 2021
  2. 2022
  3. 2023

    Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Tao Cheng (1235148)

    Published 2016
    “…The onabotulinumtoxinA-treated groups had a significantly decreased mean number of urinary incontinence episodes per week (at week 6) (onabotulinumtoxinA200U: MD: -10.72, 95% CI: -13.4 to -8.04, P<0.00001; 300 U: MD: -11.42, 95% CI: -13.91 to -8.93, P<0.00001), MDP (200 U: MD: -33.46, 95% CI: -39.74 to -27.18, P<0.00001; 300 U: MD: -31.72, 95% CI: -37.69 to -25.75, P<0.00001), and greater increased MCC (200 U: MD: 141.30, 95% CI: 121.28 to 161.32, P<0.00001; 300 U: MD: 151.39, 95% CI: 130.43 to 172.34, P<0.00001) compared to the placebo-treated groups. …”
  4. 2024
  5. 2025
  6. 2026
  7. 2027
  8. 2028
  9. 2029
  10. 2030
  11. 2031
  12. 2032
  13. 2033
  14. 2034
  15. 2035
  16. 2036
  17. 2037
  18. 2038
  19. 2039
  20. 2040